Impact of Glucocorticoids on the Gut Microbiome with or without Anti-PD-L1

被引：0
|
作者：
Tsementzi, D. [1 ]
Buchwald, Z. S. [2 ]
Qiu, L. [3 ]
Khan, M. K. [1 ]
Konstantinidis, K. [4 ]
Bruner, D. W. [5 ]
Lin, J. Y., Jr. [6 ,7 ]
机构：
[1] Emory Univ, Atlanta, GA 30322 USA
[2] Emory Univ, Dept Radiat Oncol, Winship Canc Inst, Atlanta, GA 30322 USA
[3] Emory Univ, Atlanta, GA 30322 USA
[4] Georgia Inst Technol, Sch Civil & Environm Engn, Atlanta, GA 30332 USA
[5] Emory Univ, Nell Hodgson Woodruff Sch Nursing, Atlanta, GA 30322 USA
[6] Emory Univ, Dept Radiat Oncol, Atlanta, GA 30322 USA
[7] Emory Univ, Winship Canc Inst, Atlanta, GA 30322 USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2019年 / 105卷 / 01期
关键词：
D O I：
10.1016/j.ijrobp.2019.06.969
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3552
引用
收藏
页码：E667 / E667
页数：1
相关论文
共 50 条
  • [31] Anti-PD-1 and Anti-PD-L1 Monoclonal Antibodies in People Living with HIV and Cancer
    Lurain, Kathryn
    Ramaswami, Ramya
    Yarchoan, Robert
    Uldrick, Thomas S.
    CURRENT HIV/AIDS REPORTS, 2020, 17 (05) : 547 - 556
  • [32] Anti-PD-1/Anti-PD-L1 Drugs and Radiation Therapy: Combinations and Optimization Strategies
    Boustani, Jihane
    Lecoester, Benoit
    Baude, Jeremy
    Latour, Charlene
    Adotevi, Olivier
    Mirjolet, Celine
    Truc, Gilles
    CANCERS, 2021, 13 (19)
  • [33] Effect of NK cell treatment on PD-L1 expression and anti-PD-L1 response
    Copik, Alicja
    Oyer, Jeremiah
    Gitto, Sarah
    Altomare, Deborah
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
  • [34] Anti-PD-L1 DNA aptamer antagonizes the interaction of PD-1/PD-L1 with antitumor effect
    Gao, Tian
    Mao, Zheng
    Li, Wenjing
    Pei, Renjun
    JOURNAL OF MATERIALS CHEMISTRY B, 2021, 9 (03) : 746 - 756
  • [35] Structural basis of the therapeutic anti-PD-L1 antibody atezolizumab
    Zhang, Fei
    Qi, Xiaoqiang
    Wang, Xiaoxiao
    Wei, Diyang
    Wu, Jiawei
    Feng, Lingling
    Cai, Haiyan
    Wang, Yugang
    Zeng, Naiyan
    Xu, Ting
    Zhou, Aiwu
    Zheng, Ying
    ONCOTARGET, 2017, 8 (52) : 90215 - 90224
  • [36] Anti-PD-L1 Treatment Induced Central Diabetes Insipidus
    Zhao, Chen
    Tella, Sri Harsha
    Del Rivero, Jaydira
    Kommalapati, Anuhya
    Ebenuwa, Ifechukwude
    Gulley, James
    Strauss, Julius
    Brownell, Isaac
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2018, 103 (02): : 365 - 369
  • [37] A rare case of pneumocystosis under anti-PD-L1 therapy
    Santos, Maria Joao
    Cavaco, Maria Joao
    Santos, Fernanda Paula
    Froes, Filipe
    PULMONOLOGY, 2024, 30 (06): : 671 - 672
  • [38] Anti-PD-L1 antibody active in metastatic bladder cancer
    Brower, Vicki
    LANCET ONCOLOGY, 2015, 16 (01): : E11 - E11
  • [39] A Novel Anti-PD-L1 Vaccine for Cancer Immunotherapy and Immunoprevention
    Chen, Jie
    Liu, Hui
    Jehng, Tiffany
    Li, Yanqing
    Chen, Zhoushi
    Lee, Kuan-Der
    Shen, Hsieh-Tsung
    Jones, Lindsey
    Huang, Xue F.
    Chen, Si-Yi
    CANCERS, 2019, 11 (12)
  • [40] Dynamic changes of plasma PD-L1 mRNA expression is associated with anti-PD-1/anti-PD-L1 response in malignancies
    Yang, Q.
    Chen, M.
    Gu, J.
    Zheng, L.
    Yu, Y.
    Li, F.
    Zhang, L.
    Niu, K.
    Sun, J.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2019, 49 : 1777 - 1778
12345